Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. (Q64911638)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. |
scientific article |
Statements
1 reference
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. (English)
1 reference
1 reference
1 reference
1 reference
Andrzej Hellmann
1 reference
Aleksander Skotnicki
1 reference
Jerzy Holowiecki
1 reference
Tadeusz Robak
1 reference
Saengsuree Jootar
1 reference
Hagop Kantarjian
1 reference
Ricardo Pasquini
1 reference
Philippe Rousselot
1 reference
Nina Khoroshko
1 reference
Andrey Zaritsky
1 reference
Anatoly Golenkov
1 reference
Jerald Radich
1 reference
Timothy Hughes
1 reference
Athena Countouriotis
1 reference
Neil Shah
1 reference
22 February 2007
1 reference
1 reference
109
1 reference
5143-5150
1 reference
12
1 reference
Identifiers
1 reference